R. E. Buck

614 total citations
16 papers, 452 citations indexed

About

R. E. Buck is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, R. E. Buck has authored 16 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 9 papers in Molecular Medicine and 7 papers in Infectious Diseases. Recurrent topics in R. E. Buck's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (9 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). R. E. Buck is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (9 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). R. E. Buck collaborates with scholars based in United States, Germany and Japan. R. E. Buck's co-authors include K. E. Price, F. Leitner, M Misiek, T. A. Pursiano, R E Kessler, J V Desiderio, J. Lein, Koko Sugawara, Takeo Miyaki and Minoru Hanada and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics and Infection.

In The Last Decade

R. E. Buck

16 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. E. Buck United States 9 318 194 114 82 71 16 452
M Misiek United States 11 346 1.1× 226 1.2× 102 0.9× 113 1.4× 85 1.2× 26 497
Donald Pitkin United States 15 294 0.9× 144 0.7× 116 1.0× 84 1.0× 90 1.3× 33 504
T. A. Pursiano United States 10 368 1.2× 278 1.4× 121 1.1× 116 1.4× 119 1.7× 16 548
F. Leitner United States 12 394 1.2× 259 1.3× 138 1.2× 118 1.4× 105 1.5× 29 562
Neu Hc United States 12 275 0.9× 215 1.1× 135 1.2× 66 0.8× 77 1.1× 41 520
K. A. Bedford United Kingdom 13 448 1.4× 328 1.7× 174 1.5× 97 1.2× 111 1.6× 22 672
P. B. Harper United Kingdom 9 195 0.6× 247 1.3× 104 0.9× 81 1.0× 36 0.5× 17 377
MICHAEL J. BASKER United States 12 274 0.9× 244 1.3× 81 0.7× 124 1.5× 89 1.3× 35 503
E. Schrinner Germany 14 361 1.1× 275 1.4× 150 1.3× 115 1.4× 127 1.8× 36 576
G. Beskid United States 16 219 0.7× 184 0.9× 111 1.0× 186 2.3× 81 1.1× 35 531

Countries citing papers authored by R. E. Buck

Since Specialization
Citations

This map shows the geographic impact of R. E. Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Buck more than expected).

Fields of papers citing papers by R. E. Buck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Buck. The network helps show where R. E. Buck may publish in the future.

Co-authorship network of co-authors of R. E. Buck

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Buck. A scholar is included among the top collaborators of R. E. Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Buck. R. E. Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Buck, R. E.. (2006). CONJECTURING. PRIMUS. 16(2). 97–104. 2 indexed citations
2.
Leitner, F., T. A. Pursiano, R. E. Buck, et al.. (1987). BMY 28100, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy. 31(2). 238–243. 55 indexed citations
3.
Kessler, R E, R. E. Buck, T. A. Pursiano, et al.. (1985). Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 27(2). 207–216. 141 indexed citations
4.
Misiek, M, et al.. (1985). Antibacterial activity of phosphanilic acid, alone and in combination with trimethoprim. Antimicrobial Agents and Chemotherapy. 28(6). 761–765. 3 indexed citations
5.
KONISHI, MASATAKA, Koko Sugawara, Minoru Hanada, et al.. (1984). Empedopeptin (BMY-28117), a new depsipeptide antibiotic. I. Production, isolation and properties.. The Journal of Antibiotics. 37(9). 949–957. 26 indexed citations
6.
Leitner, F., et al.. (1980). Bactericidal activity of cefadroxil, cephalexin and cephradine in an in vitro pharmacokinetic model. Infection. 8(S5). S542–S548. 7 indexed citations
7.
Buck, R. E. & K. E. Price. (1980). Cefadroxil, a new broad-spectrum cephalosporin. Infection. 8(S5). S532–S537. 4 indexed citations
8.
Leitner, F., et al.. (1979). Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model.. The Journal of Antibiotics. 32(7). 718–726. 14 indexed citations
9.
Buck, R. E., et al.. (1979). Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.. The Journal of Antibiotics. 32(7). 727–733. 8 indexed citations
10.
Buck, R. E. & K. E. Price. (1977). Cefadroxil, a New Broad-Spectrum Cephalosporin. Antimicrobial Agents and Chemotherapy. 11(2). 324–330. 92 indexed citations
11.
Leitner, F., et al.. (1976). Laboratory Evaluation of BL-S786, a Cephalosporin with Broad-Spectrum Antibacterial Activity. Antimicrobial Agents and Chemotherapy. 10(3). 426–435. 43 indexed citations
12.
Leitner, F., R. E. Buck, M Misiek, T. A. Pursiano, & K. E. Price. (1975). BL-S 640, a Cephalosporin with a Broad Spectrum of Antibacterial Activity: Properties In Vitro. Antimicrobial Agents and Chemotherapy. 7(3). 298–305. 26 indexed citations
13.
Buck, R. E., F. Leitner, & K. E. Price. (1972). 7-[α-(1-Methyl-4-Pyridinothio)-Acetamido] Cephalosporanic Acid. Antimicrobial Agents and Chemotherapy. 1(1). 67–72. 3 indexed citations
14.
Price, K. E., R. E. Buck, & J. Lein. (1964). System for Detecting Inducers of Lysogenic Escherichia coli W1709(λ) and Its Applicability as a Screen for Antineoplastic Antibodies. Applied Microbiology. 12(5). 428–435. 20 indexed citations
15.
Price, K. E., et al.. (1962). A comparison of the in vitro susceptibility of HeLa and protozoan cells to antitumor antibiotics.. PubMed. 22. 885–91. 6 indexed citations
16.
Buck, R. E.. (1951). Massive hematemesis from a cirsoid aneurysm in a forty-year-old man. Report of a fatal case.. PubMed. 74(6). 439–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026